S

Sionna Therapeutics Inc
NASDAQ:SION

Watchlist Manager
Sionna Therapeutics Inc
NASDAQ:SION
Watchlist
Price: 42.83 USD -3.12% Market Closed
Market Cap: 1.9B USD

Operating Margin
Sionna Therapeutics Inc

0%
Current
0%
Average
-4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-83.5m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

Sionna Therapeutics Inc
Glance View

Market Cap
1.9B USD
Industry
Biotechnology

Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in Waltham, Massachusetts and currently employs 28 full-time employees. The company went IPO on 2025-02-07. The firm is focused on researching and developing novel medicines for cystic fibrosis. The company is advancing a pipeline of small molecules engineered to correct the defects caused by the F508del genetic mutation, which resides in nucleotide-binding domain 1 (NBD1). The company is conducting ongoing Phase I trials of its two highly potent NBD1 stabilizers, SION-719 and SION-451, evaluating the safety, tolerability and pharmacokinetic (PK) profile of single and multiple ascending doses in healthy subjects. The company is also developing a portfolio of cystic fibrosis transmembrane conductance regulator (CFTR) modulators designed to work synergistically with its NBD1 stabilizers to improve CFTR function. Its portfolio also includes Galicaftor (SION-2222) and SION-2851, which are TMD1-directed CFTR correctors; SION-109, an ICL4-directed CFTR corrector, and Navocaftor (SION-3067), is a clinical-stage potentiator of CFTR gating activity.

SION Intrinsic Value
Not Available
S
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-83.5m
/
Revenue
0
What is the Operating Margin of Sionna Therapeutics Inc?

Based on Sionna Therapeutics Inc's most recent financial statements, the company has Operating Margin of 0%.

Back to Top